Literature DB >> 29564561

Development and endoscopic appearance of colorectal tumors are characterized by the expression profiles of miRNAs.

Yoshihito Nakagawa1, Yukihiro Akao2, Tomomitsu Tahara3, Hiromi Yamashita3, Mitsuo Nagasaka3, Tomoyuki Shibata3, Naoki Ohmiya3.   

Abstract

Accumulating data indicates that certain microRNAs (miRNAs or miRs) are differently expressed in samples of tumors and paired non-tumorous samples taken from the same patients with colorectal tumors. We previously reported to clarify the relationship between the expression of the miRNAs and the endoscopic morphological appearance of the colorectal tumors. In this report, we focused on colorectal adenoma (tubular or tubulovillous adenoma), or tubular early carcinoma or type 2 adenocarcinoma, familial adenomatous polyposis (FAP), ulcerative colitis-associated tumor (UCAT), and sessile serrated adenoma/polyp (SSA/P). We tried to clarify the relationship between the expression of the miRNAs and the colorectal tumor development. The expression levels of miR-143, -145, and -34a were reduced in most of the polypoid and FAP tumors compared with those in the flat elevated, UCAT, SSA/P ones. In type 2 adenocarcinomas, the expression profile of these miRNAs was similar to those of the polypoid and FAP tumors. The expression levels of miR-7 and -21 were up-regulated in non-granular type of laterally spreading tumor, UCAT, and SSA/P compared with those in polypoid and FAP tumors. These findings indicated that the expression of onco-related miRNAs was closely associated with the development and endoscopic appearance of colorectal tumors.

Entities:  

Keywords:  Adenoma–carcinoma sequence; Colorectal tumor development; Flat elevated tumor; Onco-related microRNA; Sessile serrated adenoma/polyp; Ulcerative colitis-associated tumor

Mesh:

Substances:

Year:  2018        PMID: 29564561     DOI: 10.1007/s00795-018-0186-y

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  51 in total

Review 1.  The molecular landscape of colitis-associated carcinogenesis.

Authors:  Deborah Saraggi; Matteo Fassan; Claudia Mescoli; Marco Scarpa; Nicola Valeri; Andrea Michielan; Renata D'Incá; Massimo Rugge
Journal:  Dig Liver Dis       Date:  2016-12-21       Impact factor: 4.088

2.  Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer.

Authors:  Remco Nagel; Carlos le Sage; Begoña Diosdado; Maike van der Waal; Joachim A F Oude Vrielink; Anne Bolijn; Gerrit A Meijer; Reuven Agami
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

3.  Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines.

Authors:  K Hashimoto; Y Nakagawa; H Morikawa; M Niki; Y Egashira; I Hirata; K Katsu; Y Akao
Journal:  Carcinogenesis       Date:  2001-12       Impact factor: 4.944

4.  Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum.

Authors:  T Uraoka; Y Saito; T Matsuda; H Ikehara; T Gotoda; D Saito; T Fujii
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

5.  Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations.

Authors:  Sakiko Hiraoka; Jun Kato; Masashi Tatsukawa; Keita Harada; Hideyuki Fujita; Tamiya Morikawa; Hidenori Shiraha; Yasushi Shiratori
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

6.  Analysis of K-ras mutations and expression of cyclooxygenase-2 and gastrin protein in laterally spreading tumors.

Authors:  Kenichiroh Mukawa; Shigehiko Fujii; Jun Takeda; Kazuaki Kitajima; Keiichi Tominaga; Yoko Chibana; Mikio Fujita; Kazuhito Ichikawa; Shigeki Tomita; Yuko Ono; Johji Imura; Hitoshi Kawamata; Tsutomu Chiba; Hideyuki Hiraishi; Akira Terano; Takahiro Fujimori
Journal:  J Gastroenterol Hepatol       Date:  2005-10       Impact factor: 4.029

7.  Role of anti-oncomirs miR-143 and -145 in human colorectal tumors.

Authors:  Y Akao; Y Nakagawa; I Hirata; A Iio; T Itoh; K Kojima; R Nakashima; Y Kitade; T Naoe
Journal:  Cancer Gene Ther       Date:  2010-01-22       Impact factor: 5.987

8.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

9.  MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.

Authors:  Binghong Xiong; Yong Cheng; Li Ma; Caiquan Zhang
Journal:  Int J Oncol       Date:  2012-11-20       Impact factor: 5.650

10.  Impairment of K-Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR-143.

Authors:  Yukihiro Akao; Minami Kumazaki; Haruka Shinohara; Nobuhiko Sugito; Yuki Kuranaga; Takuya Tsujino; Yuki Yoshikawa; Yukio Kitade
Journal:  Cancer Sci       Date:  2018-04-14       Impact factor: 6.716

View more
  3 in total

1.  Microsatellite instability in the high-grade dysplasia component of duodenal adenoma is associated with progression to adenocarcinoma.

Authors:  Nobuyoshi Aso; Kouki Ohtsuka; Junji Shibahara; Hirotomo Koda; Teppei Morikawa; Nobutsugu Abe; Takashi Watanabe; Hiroaki Ohnishi
Journal:  Surg Today       Date:  2022-07-24       Impact factor: 2.540

2.  MicroRNA Profile of Human Small Intestinal Tumors Compared to Colorectal Tumors.

Authors:  Yoshihito Nakagawa; Yukihiro Akao; Hiromi Yamashita; Tomomitsu Tahara; Kohei Funasaka; Mitsuo Nagasaka; Teiji Kuzuya; Ryoji Miyahara; Senju Hashimoto; Tomoyuki Shibata; Yoshiki Hirooka
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

3.  Induced miR-31 by 5-fluorouracil exposure contributes to the resistance in colorectal tumors.

Authors:  Yoshihito Nakagawa; Yuki Kuranaga; Tomomitsu Tahara; Hiromi Yamashita; Tomoyuki Shibata; Mitsuo Nagasaka; Kohei Funasaka; Naoki Ohmiya; Yukihiro Akao
Journal:  Cancer Sci       Date:  2019-07-23       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.